Sana Biotechnology, Inc.

SANAReported to SECin USCIK 0001770121Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 4 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

4
Form 4 lines at Sana Biotechnology, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
PATEL DHAVALKUMAR DHIRAJLALEVP, Chief Scientific OfficerOption exercisenothing paid125,000 sharesAug 27, 2026PATEL DHAVALKUMAR DHIRAJLALEVP, Chief Scientific Officernothing paidExercise · Aug 27Option exercise125,000Aug 27, 2026
PATEL DHAVALKUMAR DHIRAJLALEVP, Chief Scientific OfficerAdministrative$169,15941,158 sharesAug 27, 2026PATEL DHAVALKUMAR DHIRAJLALEVP, Chief Scientific Officer$169,159Admin · Aug 27Administrative41,158Aug 27, 2026
PATEL DHAVALKUMAR DHIRAJLALEVP, Chief Scientific OfficerOption exercisenothing paid125,000 sharesAug 27, 2026PATEL DHAVALKUMAR DHIRAJLALEVP, Chief Scientific Officernothing paidExercise · Aug 27Option exercise125,000Aug 27, 2026
Bishop Hans Edgar—Awardnothing paid6,297 sharesJul 7, 2026Bishop Hans Edgarnothing paidAward · Jul 7Award6,297Jul 7, 2026